Managing Cardiovascular Emergencies: Collaborative Approaches Involving Nursing, operations, Anesthesia, Public Health, and Health Administration
Main Article Content
Keywords
“Cardiovascular”, “Emergencies”, “heart failure”, “health worker”, “vasopressor”, “Management”,’ cardiogenic shock’.
Abstract
Healthcare professional’s management of cardiovascular emergency situation in patient with critical illness is important to be analyzed. The multidisciplinary approaches across health care team and their collaboration can improve the quality of the management and reduce the complication that may occur. Cardiogenic shock, acute heart failure and myocardial infarction are from the life-threatening cardiovascular emergency issues that need a critical and instant intervention and management. Healthcare professional frequently encounter difficult clinical situations by selecting drugs based on comorbidities, the assessment of hemodynamics should be used to carefully guide treatment. Vasopressors, inotropes, and mechanical circulatory support are useful in some patients but are not always advised. In order to effectively manage cardiovascular emergency situations, early diagnosis, precise hemodynamic assessment, and timely therapeutic intervention are essential. In addition, healthcare providers should close the knowledge gap between evidence-based medicine and clinical practice.
References
De Luca G., Suryapranata H., Ottervanger J. P., Antman E. M. (2004). Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation.;109(10):1223–1225.
Chang YJ, Chang SL, Chong E, Suenari K, Michalopoulos A. (2017). Cardiovascular Emergencies. Biomed Res Int.:7210261. doi: 10.1155/2017/7210261.
World Health Organization (2021). Cardiovascular diseases (CVDs).
Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M. (2010). Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 11;55(19):2062-76.
Gheorghiade M, Zannad F, Sopko G, et al. (2005). Acute heart failure syndromes: current state and framework for future research. Circulation; 112: 3958–68.
Adams KF Jr, Fonarow GC, Emerman CL, et al. (2005). Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J; 149: 209–16.
Fonarow GC, Abraham WT, Albert NM, et al (2004). Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J; 148: 43–51.
Storrow AB, Jenkins CA, Self WH, et al (2014). The burden of acute heart failure on U.S. emergency departments. JACC. Heart Failure; 2: 269–77.
Jollis J. G., Granger C. B. (2016). Improving Care of Out-of-Hospital Cardiac Arrest: Next Steps. Circulation. 134(25):2040–2042.
Nielsen N., Wetterslev J., Friberg H., TTM Trial Steering Group Targeted temperature management after cardiac arrest. The New England journal of medicine. 2014;370(14): p. 1360.
Belletti A, Castro M.L. Silvetti S. GrecoT. Biondi-Zoccai G. Pasin L et al (2015). The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials Vol 115, Issue 5, P656-675
Jia Z, Guo M, Zhang LY, Zhang YQ, Liang HQ, Song Y (2015). Levosimendan and Nesiritide as a Combination Therapy in Patients with Acute Heart Failure.; 349: 398-405Triposkiadis FK
Pasqui AL, Maffei S, Di Renzo M, Pompella G, Auteri A, Puccetti L (2011). Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study.147: 314-315
Butler J, Karayannis G et al. (2014). Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.; 172: 115-121
Packer M, Colucci W, Fisher L et al. (2013). Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.JACC Heart Fail. ; 1: 103-111
Liorens P, Miró Ò,Román F,Zapater P, Carbajosa-Dalmau J, Llanos L (2012) Efficacy of early administration of levosimendan in emergency department in patients with acute heart failure: a randomized pilot clinical trial. Emergencias. 24: 268-276
Kurt IH, Yavuzer K, Batur MK (2010). Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure. Heart Vessels; 25: 392-399
Biteker M, Duran NE, Kaya H et al (2011). Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial; 100: 571-577
Adamopoulos S, Parissis JT, Iliodromitis EK et al (2006). Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.Am J Cardiol. 98: 102-106
Ducros L,Vicaut E ,Soleil C et al.(2011).Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans.; 41: 453-459
Husebye T, Eritsland J, Müller C et al. (2013). Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.15: 565-572
Giamouzis G, Butler J, Starling RC et al. (2010). Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.; 16: 922-930
Jacobs IG, Finn JC, Jelinek GA, Oxer HF, Thompson PL (2011). Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomized double-blind placebo-controlled trial.Resuscitation. 82: 1138-1143
Silvetti S, Greco T, Di Prima AL et al. (2014). Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.; 103: 505-513
Landoni G, Biondi-Zoccai G, Greco M et al. (2012). Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.; 40: 634-646
Mebazaa A, Parissis J, Porcher R et al. (2011). Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods.37: 290-301
Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S. (2018). Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Johnson NJ, Salhi RA, Abella BS, Neumar RW, Gaieski DF, Carr BG. (2013). Emergency department factors associated with survival after sudden cardiac arrest. Resuscitation. 84(3):292-7.
Sehgal A, Francis JV, Lewis AI. (2011) Use of milrinone in the management of haemodynamic instability following duct ligation. European Journal of Pediatrics;170(1):115‐9.
Pietrangelo T, Giampietro L, De Filippis B, La Rovere R, Fulle S, Amoroso R. (2010). Effect of milrinone analogues on intracellular calcium increase in single living H9C2 cardiac cells. European Journal of Medicinal Chemistry;45(11):4928‐33.
Prabhakaran K., Azim A., Khan M. et al. (2020). “Predicting the need for tracheostomy in trauma patients without severe head injury,” The American Journal of Surgery, vol. 220, pp. 495–498,
Rognoni A, Lupi A, Lazzero M, Bongo AS, Rognoni G. (2011) Levosimendan: from basic science to clinical trials. Recent Patents on Cardiovascular Drug Discovery 6(1):9‐15.
Levy B, Perez P, Perny J, Thivilier C, Gerard A. (2011). Comparison of norepinephrine‐dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Critical Care Medicine 2011;39(3):450‐5.
Song L, Lu H, Ru H, Zhao X, (2021). Investigation on the Effect of Graded Emergency Nursing Group under the Assistance of Multidisciplinary First Aid Knowledge Internet-Based Approach on the First Aid of Acute Myocardial Infarction", Journal of Healthcare Engineering, 8469930, 6 pages,
Chang YJ, Chang SL, Chong E, Suenari K, Michalopoulos A. (2017). Cardiovascular Emergencies. Biomed Res Int.:7210261. doi: 10.1155/2017/7210261.
World Health Organization (2021). Cardiovascular diseases (CVDs).
Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M. (2010). Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 11;55(19):2062-76.
Gheorghiade M, Zannad F, Sopko G, et al. (2005). Acute heart failure syndromes: current state and framework for future research. Circulation; 112: 3958–68.
Adams KF Jr, Fonarow GC, Emerman CL, et al. (2005). Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J; 149: 209–16.
Fonarow GC, Abraham WT, Albert NM, et al (2004). Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J; 148: 43–51.
Storrow AB, Jenkins CA, Self WH, et al (2014). The burden of acute heart failure on U.S. emergency departments. JACC. Heart Failure; 2: 269–77.
Jollis J. G., Granger C. B. (2016). Improving Care of Out-of-Hospital Cardiac Arrest: Next Steps. Circulation. 134(25):2040–2042.
Nielsen N., Wetterslev J., Friberg H., TTM Trial Steering Group Targeted temperature management after cardiac arrest. The New England journal of medicine. 2014;370(14): p. 1360.
Belletti A, Castro M.L. Silvetti S. GrecoT. Biondi-Zoccai G. Pasin L et al (2015). The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials Vol 115, Issue 5, P656-675
Jia Z, Guo M, Zhang LY, Zhang YQ, Liang HQ, Song Y (2015). Levosimendan and Nesiritide as a Combination Therapy in Patients with Acute Heart Failure.; 349: 398-405Triposkiadis FK
Pasqui AL, Maffei S, Di Renzo M, Pompella G, Auteri A, Puccetti L (2011). Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study.147: 314-315
Butler J, Karayannis G et al. (2014). Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.; 172: 115-121
Packer M, Colucci W, Fisher L et al. (2013). Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.JACC Heart Fail. ; 1: 103-111
Liorens P, Miró Ò,Román F,Zapater P, Carbajosa-Dalmau J, Llanos L (2012) Efficacy of early administration of levosimendan in emergency department in patients with acute heart failure: a randomized pilot clinical trial. Emergencias. 24: 268-276
Kurt IH, Yavuzer K, Batur MK (2010). Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure. Heart Vessels; 25: 392-399
Biteker M, Duran NE, Kaya H et al (2011). Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial; 100: 571-577
Adamopoulos S, Parissis JT, Iliodromitis EK et al (2006). Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.Am J Cardiol. 98: 102-106
Ducros L,Vicaut E ,Soleil C et al.(2011).Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans.; 41: 453-459
Husebye T, Eritsland J, Müller C et al. (2013). Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.15: 565-572
Giamouzis G, Butler J, Starling RC et al. (2010). Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.; 16: 922-930
Jacobs IG, Finn JC, Jelinek GA, Oxer HF, Thompson PL (2011). Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomized double-blind placebo-controlled trial.Resuscitation. 82: 1138-1143
Silvetti S, Greco T, Di Prima AL et al. (2014). Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.; 103: 505-513
Landoni G, Biondi-Zoccai G, Greco M et al. (2012). Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.; 40: 634-646
Mebazaa A, Parissis J, Porcher R et al. (2011). Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods.37: 290-301
Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S. (2018). Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Johnson NJ, Salhi RA, Abella BS, Neumar RW, Gaieski DF, Carr BG. (2013). Emergency department factors associated with survival after sudden cardiac arrest. Resuscitation. 84(3):292-7.
Sehgal A, Francis JV, Lewis AI. (2011) Use of milrinone in the management of haemodynamic instability following duct ligation. European Journal of Pediatrics;170(1):115‐9.
Pietrangelo T, Giampietro L, De Filippis B, La Rovere R, Fulle S, Amoroso R. (2010). Effect of milrinone analogues on intracellular calcium increase in single living H9C2 cardiac cells. European Journal of Medicinal Chemistry;45(11):4928‐33.
Prabhakaran K., Azim A., Khan M. et al. (2020). “Predicting the need for tracheostomy in trauma patients without severe head injury,” The American Journal of Surgery, vol. 220, pp. 495–498,
Rognoni A, Lupi A, Lazzero M, Bongo AS, Rognoni G. (2011) Levosimendan: from basic science to clinical trials. Recent Patents on Cardiovascular Drug Discovery 6(1):9‐15.
Levy B, Perez P, Perny J, Thivilier C, Gerard A. (2011). Comparison of norepinephrine‐dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Critical Care Medicine 2011;39(3):450‐5.
Song L, Lu H, Ru H, Zhao X, (2021). Investigation on the Effect of Graded Emergency Nursing Group under the Assistance of Multidisciplinary First Aid Knowledge Internet-Based Approach on the First Aid of Acute Myocardial Infarction", Journal of Healthcare Engineering, 8469930, 6 pages,
Article Sidebar
Published
Mar 23, 2022
Article Details
How to Cite
Mohammed Hamoud Essa Alqayd8, Raznah Abdullah Mahdi Alqahtani9, Norah Nasser Mohamed Alqahtani10, Haya Nasser Mohamed Alqahtani 11, Wafa Nasser Saeed Alshahrani12, F. M. Y. A. D. A. H. A. A. A. M. A. T. M. H. E. A. Z. Y. H. N. 5, A. H. H. A. A. M. A. T. (2022). Managing Cardiovascular Emergencies: Collaborative Approaches Involving Nursing, operations, Anesthesia, Public Health, and Health Administration. Journal of Population Therapeutics and Clinical Pharmacology, 29(03), 802-812. https://doi.org/10.53555/jptcp.v29i03.5856
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Mohammed Hamoud Essa Alqayd8, Raznah Abdullah Mahdi Alqahtani9, Norah Nasser Mohamed Alqahtani10, Haya Nasser Mohamed Alqahtani 11, Wafa Nasser Saeed Alshahrani12, F. M. Y. A. D. A. H. A. A. A. M. A. T. M. H. E. A. Z. Y. H. N. 5, A. H. H. A. A. M. A. T. (2022). Managing Cardiovascular Emergencies: Collaborative Approaches Involving Nursing, operations, Anesthesia, Public Health, and Health Administration. Journal of Population Therapeutics and Clinical Pharmacology, 29(03), 802-812. https://doi.org/10.53555/jptcp.v29i03.5856